The QualityStocks Daily Friday, March 15th, 2024

Today's Top 3 Investment Newsletters

QualityStocks(VERB) $0.4422 +211.41%

Schaeffer's(GERN) $3.3600 +92.00%

360 Wall Street(CDLX) $14.5000 +77.15%

The QualityStocks Daily Stock List

Verb Technology (VERB)

QualityStocks, MarketClub Analysis, MarketBeat, TradersPro, StockMarketWatch, InvestorPlace, BUYINS.NET, Small Cap Firm, StockWireNews, AwesomeStocks, Fierce Analyst, Broad Street, Money Wealth Matters, StockStreetWire, The Stock Dork and INO Market Report reported earlier on Verb Technology (VERB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Verb Technology Company Inc. (NASDAQ: VERB) (FRA: 37V) operates as a Software-as-a-Service applications platform developer internationally as well as in Japan and the U.S.

The firm has its headquarters in American Fork, Utah and was incorporated in 2012 on November 27th by Rory J. Cutaia. Prior to its name change in February 2019, the firm was known as nFusz. It operates as part of the computer software industry in the technology sector, under the software sub-industry.

The company serves the growing CBD industry, clients in the health care industry, not-for-profit organizations, home security firms and real estate companies as well as insurance, auto leasing, auto sales, educational institutions and large professional associations. It has two companies in its corporate family and serves consumers across the globe.

The enterprise provides a live e-commerce application known as verbLIVE and a learning management system application dubbed verbLEARN, which integrates clickable in-video technology featured in its CRM application. It also provides a CRM application (customer relationship management) for solopreneurs and medium and small-scale businesses dubbed verbTEAMS and a CRM application known as verbCRM. In addition to this, the enterprise offers non-digital services to enterprise clients, like printing and design services for starter and welcome kits; subscription-based services; and fulfilment services, such as managing the shipping, handling and/or preparation of custom-branded merchandise.

Many consider the future of e-commerce to be livestream shopping. The company is well-positioned to benefit from the expected growth of live stream shopping in the U.S. given the presence of its verbLIVE application. The company may experience growth as well as an increase in investments as livestream shopping, which is a billion-dollar industry, continues to grow.

Verb Technology (VERB), closed Friday's trading session at $0.4422, up 211.4084%, on 546,472,938 volume. The average volume for the last 3 months is 10.478M and the stock's 52-week low/high is $0.1144/$5.108.

Geron Corporation (GERN)

Greenbackers, Market Report, StocksEarning, The Street, Schaeffer's, MarketClub Analysis, MarketBeat, StreetInsider, Wall Street Resources, PennyStocks24, Hit and Run Candle Sticks, StockMarketWatch, StockTradersHQ, InvestorPlace, TraderPower, BUYINS.NET, QualityStocks, MicroCapINPLAY, SmarTrend Newsletters, Investment House, SmallCapVoice, Stock Analyzer, Today's Financial News, Wealth Insider Alert, INO Market Report, StockEarnings, Trades Of The Day, StockOodles, Street Insider, PennyOmega, Daily Markets, Daily Trade Alert,, PennyToBuck, TradersPro, The Momentum Traders Network, The Best Newsletters, TheStockAdvisors, Top Stock Picks, TopStockAnalysts, Jason Bond, The Motley Fool, Investopedia, Investment U, Insider Wealth Alert, Kiplinger Today, FeedBlitz, Market Intelligence Center,, Earnings360, Darwin Investing Network, Wealth Daily, Wealthpire Inc., Daily Market Beat, CRWEWallStreet, CRWEPicks, CRWEFinance, CoolPennyStocks, Weekly Wizards, Trading Concepts, Penny Stock, SpeculatingStocks, Short Term Wealth, Stock Research Newsletter, Rick Saddler, Stock Tips Network, PennyTrader Publisher, Zacks, StockHotTips, BestOtc, Stockhouse, MadPennyStocks, Penny Stock Buzz, PennyStockProphet, OTCPicks, OTC Advisors, OnTheMar, Money Morning, Momentum Trades, Momentum Traders, StreetAuthority Daily, Streetwise Reports, smartOTC, Market FN and PennyInvest reported earlier on Geron Corporation (GERN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Geron Corporation (NASDAQ: GERN) (FRA: GON) is a late-stage biopharmaceutical firm that is engaged in the development and commercialization of therapies for hematologic myeloid malignancies like myelodysplastic syndromes, acute myelogenous leukemia and myelofibrosis.

Geron Corporation is based in Menlo Park, California and was founded on November 28, 1990 by Michael D. West. The firm develops pharmaceuticals based off of protein inhibitor technologies whose objective is to demolish enzymes that feed cancerous cells.

Geron Corporation operates through one segment, which is engaged in the development of oncological therapeutic products. The firm serves consumers in the state of California.

Geron Corporation’s product portfolio includes a lipid conjugated oligonucleotide which has been designed to be complementary to, and bind with, high affinity to the RNA telomerase template, which helps to directly inhibit telomerase activity. The candidate, which is known as imetelstat, allows recovery of normal blood cell production while reducing dysfunctional blood cell production. Geron Corporation holds rights to the candidate, which is currently undergoing a phase 2/3 clinical trial for lower risk myelodysplastic syndromes dubbed IMerge and a phase 2 clinical trial for high-risk or low risk myelofibrosis dubbed IMbark.

Geron Corporation recently publicized data from their IMerge phase 2/3 clinical trial on low risk myelodysplastic syndromes, with results providing strong evidence that the candidate’s potential disease-modifying potential would allow the drug to be approved as a treatment for myelodysplastic syndromes in the near future.

Geron Corporation (GERN), closed Friday's trading session at $3.36, up 92%, on 111,710,980 volume. The average volume for the last 3 months is 6.542M and the stock's 52-week low/high is $1.64/$3.735.

Better Therapeutics (BTTX)

QualityStocks, Trades Of The Day, TradersPro, StocksEarning, Prism Market View, PennyStockProphet, MarketClub Analysis, MarketBeat, InvestorPlace and InsiderTrades reported earlier on Better Therapeutics (BTTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Better Therapeutics Inc. (NASDAQ: BTTX) is a biotechnology firm that is focused on the development of prescription digital therapeutics.

The firm has its headquarters in San Francisco, California and was incorporated in 2015. Prior to its name change, the firm was known as Mountain Crest Acquisition Corp II. The firm serves consumers around the globe.

The company builds prescription digital therapeutics which deliver a new kind of behavioral therapy and create feedback mechanisms through the use of patient-generated and remotely-monitored data. It has designed a proprietary platform which is used to develop software-based, FDA-regulated solutions for various conditions. The company validates its software via multiple clinical trials and commercializes it to private health insurance firms.

The enterprise develops treatments that reverse illness progression, improve quality of life of patients and inform clinical decisions. They include BT-001 and BT-002, which have been developed to treat uncontrolled type 2 diabetes; BT-003 which is indicated for the treatment of hypertension; and BT-004, which is used to treat hyperlipidemia. It also develops a new form of behavioral therapy known as nutritional cognitive behavioral therapy, which is indicated for the treatment of patients with cardiometabolic ailments like type 2 diabetes, stroke and non-alcoholic fatty liver disease.

The company recently appointed a new chief strategy officer who has decades of experience in using technology to transform healthcare. This decision will help the company achieve its objective to transform the treatment of cardiometabolic diseases, which will in turn be good for its growth and investments into the company.

Better Therapeutics (BTTX), closed Friday's trading session at $0.0446, up 27.4286%, on 204,525,202 volume. The average volume for the last 3 months is 580,130 and the stock's 52-week low/high is $0.0308/$1.61.

aTyr Pharma (LIFE)

StreetInsider, MarketBeat, BUYINS.NET, QualityStocks, The Street, InvestorPlace, Daily Markets, TraderPower, StockMarketWatch, Daily Trade Alert,, Street Insider, Money Morning, Barchart, StreetAuthority Daily, MarketClub Analysis, The Growth Stock Wire, The Online Investor, Investor Ideas, Stock Beast, Investors Alley, Market Authority, Investment U, InsiderTrades, FNNO Newsletters, CRWEFinance, InvestorGuide, Schaeffer's, Standout Stocks, Zacks, Stock Market Watch, StockHotTips, The Motley Fool, The Stock Enthusiast, The Trading Report, The Tycoon Report, TheStockAdvisor, TopStockAnalysts, Trades Of The Day, TradingAuthority Daily, TradingMarkets and SmarTrend Newsletters reported earlier on aTyr Pharma (LIFE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

aTyr Pharma Inc. (NASDAQ: LIFE) (FRA: 471A) is a biotherapeutics firm that is focused on discovering and developing medicines based on new immunological pathways.

The firm has its headquarters in San Diego, California and was incorporated in 2005, on September 8th by Bruce Beutler, Xiang-Lei Yang and Paul Schimmel. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United States.

The company’s focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It is party to a collaboration and license agreement with Kyorin Pharmaceutical Co. Ltd, which involves developing and commercializing efzofitimod for interstitial lung diseases in Japan.

The enterprise’s product pipeline is comprised of a fully humanized monoclonal antibody dubbed ATYR2810, which is in preclinical development for the treatment of solid tumors. It also develops a selective NRP2 (Neuropilin-2) modulator dubbed efzofitimod (ATYR1923), which downregulates the adaptive and innate immune responses in inflammatory illness states. This candidate is in phase 1b/2a trials evaluating its effectiveness in treating interstitial lung illnesses like connective tissue disease related interstitial lung disease and chronic hypersensitivity pneumonitis. This inhibitor is also is phase 2 trials testing its efficacy in treating pulmonary sarcoidosis.

The firm remains focused on advancing its efzofitimod candidate, which has shown promise in the treatment of pulmonary sarcoidosis. The success and approval of this formulation by the FDA will not only benefit patients with this indication but also bring in additional revenues and investments into the firm, which will be good for its growth.

aTyr Pharma (LIFE), closed Friday's trading session at $1.99, up 22.8395%, on 1,442,771 volume. The average volume for the last 3 months is 910,105 and the stock's 52-week low/high is $1.0801/$2.6999.

Curaleaf Hldgs, Inc. (CURLF)

InvestorPlace, Kiplinger Today, QualityStocks, MarketBeat, Cabot Wealth, Daily Trade Alert, Top Pros' Top Picks, MarketClub Analysis, Profit Trends, The Online Investor, StreetInsider, Wealth Insider Alert, Early Bird, Trades Of The Day, Trading For Keeps, The Street, Investment U, Daily Profit, CFN Media Group, StreetAuthority Daily, Zacks, TradersPro, Wyatt Investment Research, wyatt research newsletter and Schaeffer's reported earlier on Curaleaf Hldgs, Inc. (CURLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Curaleaf Hldgs, Inc. is a foremost vertically integrated medical and wellness cannabis operator in the U.S. The Company crafts premier cannabis products and its commitment is to being the industry’s foremost resource in education and advancement via research and advocacy. Curaleaf Hldgs’ shares trade on the OTC Markets Group’s OTCQX. The Company is based in Wakefield, Massachusetts.

Curaleaf has a presence in 14 states. It owns and operates 53 dispensaries, 15 cultivation sites, and 24 processing sites with an emphasis on highly populated, limited license States. These include Florida, Massachusetts, New Jersey and New York.

Curaleaf is positioned as a leading source for premium cannabis products. The Company’s brands include Select Cannabis, Curaleaf Hemp, and UKU Cannabis. Curaleaf has a team of physicians, pharmacists, medical experts and industry visionaries. Through this team the Company has created a premier, branded, cannabis-based wellness offering under the Curaleaf brand.

Curaleaf’s premium branded products include oils for vaporizing, cartridges, concentrates, tinctures, mints, capsules, edibles, and flower pods. Strain-specific terpene profiles have been launched in every State. The Company’s dedicated dispensary team have served greater than 165,000 registered patients since the inception of operations in each medical State.

Curaleaf Hldgs, Inc. (CURLF), closed Friday's trading session at $4.96, up 21.8673%, on 1,235,091 volume. The average volume for the last 3 months is 11,991 and the stock's 52-week low/high is $2.19/$5.80.

PharmaCielo (PCLOF)

QualityStocks and MarketBeat reported earlier on PharmaCielo (PCLOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

PharmaCielo Limited (OTC: PCLOF) (CVE: PCLO) is a pharmaceutical firm involved in the cultivation, processing, production and supply of medicinal-grade cannabis extracts, THC (tetrahydrocannabinol) and related products.

The firm has its headquarters in Toronto, Canada and was incorporated in 2014, on July 14th. It operates as part of the drug manufacturers-specialty and generic industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on those in Canada, Colombia, Italy, and Mexico.

The company is party to a strategic partnership with Benuvia Operations LLC, involving the manufacture of GMP pharmaceutical-grade CBD isolate and related products.

The enterprise's principal and wholly owned subsidiaries are PharmaCielo Colombia Holdings S.A.S. and Ubiquo Telemedicina S.A.S. PharmaCielo Colombia is focused on cultivating and processing the company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both THC and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool. The enterprise generates the majority of its revenue from sales of cannabis derivative products in Colombia.

The firm remains focused on pharmaceutical development and fulfilling demand as its global consumer base continues to grow. This may encourage additional investments into the firm while also bringing in additional revenues into the firm.

PharmaCielo (PCLOF), closed Friday's trading session at $0.10463, off by 1.1059%, on 150 volume. The average volume for the last 3 months is 220,675 and the stock's 52-week low/high is $0.07915/$0.22.

Cognition Therapeutics Inc. (CGTX)

MarketBeat, The Stock Dork and QualityStocks reported earlier on Cognition Therapeutics Inc. (CGTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cognition Therapeutics (NASDAQ: CGTX), a clinical-stage company developing product candidates designed to treat neurodegenerative disorders, has closed on its previously announced underwritten public offering. The offering was comprised of 6,571,428 shares of its common stock. According to the announcement, each share of common stock was sold at $1.75 per share, resulting in approximately $11.5 million in gross proceeds before deductions, commissions and expenses. Cognition Therapeutics anticipates using the funds from the offering for research, clinical development, process development and manufacturing, working capital, capital expenditures and other general corporate purposes. Titan Partners Group, a division of American Capital Partners, acted as sole book-running manager for the offering.

To view the full press release, visit

About Cognition Therapeutics Inc.

Cognition Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. The company is currently investigating its lead candidate CT1812 in clinical programs in Alzheimer’s disease, dementia with Lewy bodies (“DLB”) and dry age-related macular degeneration (“dry AMD”). The company believes CT1812 and its pipeline of σ-2 receptor modulators can regulate pathways that are impaired in these diseases. Cognition Therapeutics also believes that targeting the σ-2 receptor with CT1812 represents a mechanism functionally distinct from other current approaches in clinical development for the treatment of degenerative diseases. For more information about the company, please visit

Cognition Therapeutics Inc. (CGTX), closed Friday's trading session at $1.82, up 2.2472%, on 275,010 volume. The average volume for the last 3 months is 2.218M and the stock's 52-week low/high is $0.9001/$3.49.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, Kiplinger Today, MarketClub Analysis, The Street, StocksEarning, MarketBeat, Daily Trade Alert, Trades Of The Day, QualityStocks, Wealth Insider Alert, The Online Investor, Market Intelligence Center Alert, StockMarketWatch, StockEarnings, StreetInsider, BUYINS.NET, Zacks, The Wealth Report, Investopedia, Top Pros' Top Picks, Stock Up Featured, Cabot Wealth, InvestmentHouse, Daily Profit, Early Bird, InsiderTrades, Jim Cramer, The Rich Investor, InvestorsObserver Team, Wall Street Window, InvestorsUnderground, Money Morning, TheTradingReport, 24/7 Trader, Small Cap Firm, Stock Gumshoe and VectorVest reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Missouri Department of Health and Senior Services (DHSS) is set to begin receiving the next wave of applications for microbusiness licenses electronically, using its online registry platform. The application window is slated to open from April 15 to April 29, 2024, with licensing expected to be finalized by July.

Last year, the department granted 48 licenses for microbusiness establishments, marking the conclusion of the initial phase in a series of three rounds for the allocation of such licenses.

Microbusinesses refer to licenses for cannabis facilities exclusively available to qualifying individuals and entities and are aimed at facilitating the involvement of underrepresented and marginalized persons in the legal cannabis industry. Unlike dispensaries, microbusinesses are subject to a growth ceiling of 250 flowering plants and are authorized for the transportation, manufacturing and packaging of cannabis products.

Before the application period opens, DHSS has provided potential applicants with several guidelines, including the following:

  • Applicants may apply for only one microbusiness facility license, which could be either for a dispensary or a wholesale facility.
  • Applicants are ineligible if any of their owners possess an ownership stake in an existing comprehensive, medical or any other microbusiness cannabis facility certification or license. This condition is to ensure a level playing field for all applicants.
  • The selection of microbusiness license recipients will be conducted through a random lottery draw, devoid of any consideration of the applicants’ identities. The Missouri Lottery will oversee this process to uphold its integrity.
  • Following the closure of the application window, qualifying candidates will be categorized by license type (dispensary or wholesale) and congressional. Subsequently, each group will be assigned a unique sequential identifier for the lottery draw, resulting in a total of 16 lottery sets.
  • All applications submitted on time and with the requisite fee will be taken into account for the lottery. On the other hand, late entries or applications without the required payment will be disqualified.
  • The lottery drawing, scheduled for June 2024, will determine the order of applicants within each congressional district. All applicants will receive notification via email of their applicant identifier before the lottery drawing.
  • The results of the lottery drawing will be made public on the department’s website once they become available.

The department is expected to issue a minimum of 144 licenses by the third round, comprising 96 for wholesale vendors and 48 for dispensaries. According to state legislation, the licenses must be distributed evenly across Missouri’s eight districts.

The measures to expand the cannabis industry in Missouri are likely to be a welcome development for established companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), which would be happy to see prohibition rolled back across the country.

Cronos Group Inc. (CRON), closed Friday's trading session at $2.1, up 6.0606%, on 3,040,601 volume. The average volume for the last 3 months is 473,746 and the stock's 52-week low/high is $1.64/$2.64.

Arch Resources Inc. (ARCH)

The Online Investor, QualityStocks, InvestorPlace, Zacks, MarketBeat, DividendStocks, Investors Alley, MarketClub Analysis, TradersPro, Schaeffer's, Kiplinger Today, The Street, Daily Wealth, MiningNewsWire, StreetAuthority Daily, Trades Of The Day, Cabot Wealth, Daily Trade Alert, Uncommon Wisdom, Early Bird, FreeRealTime, InvestorGuide, Smart Investing Society, Barchart, StreetInsider and Investing Daily reported earlier on Arch Resources Inc. (ARCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

During the China Coal Import International Summit held in Xiamen, the National Coal Association of China revealed that the country was nearing peak coal consumption. Zhang Hong, the association’s deputy-secretary general, added that concerns on energy security would cause coal use to level for a while after it peaked. He also noted that the growth recorded in the solar and wind industry in 2023 would decrease coal demand in the power sector.

This announcement comes after China Petrochemical Corp stated late last year that it expected the country’s consumption of coal to hit almost 4.4 billion metric tons by 2025. In its 2060 outlook, the company forecasted that by 2045, nonfossil supplies of energy led by wind and solar would become the dominant source of energy for more than one-half of primary energy consumption.

At the moment, however, China consumes and mines more than one-half of the coal produced globally. For the last 10 years, more than 20% of CO2 emissions produced globally from fossil fuels annually have originated from the combustion of coal in China. Estimates from the International Energy Agency show that last year, coal-fired power generation in China rose by 7%, driven by a drought that decreased availability of hydropower.

Another report from the agency also forecasts that coal consumption will drop in China this year and level off for a two-year period.

China president Xi Jinping has stated that coal use in the country will reduce beginning 2026. This aligns with the country’s fifteenth five-year plan, running from 2026 to 2030, where China’s policymakers agreed to begin phasing down the use of coal.

Despite the above estimates and statements, however, evidence suggests that coal use will continue to increase in China. Christopher de Vere Walker, Carbon Tracker’s head of power and utilities research, stated that the issues with the country’s grid system made the transition toward renewable energy harder.

Currently, China’s grid is operated on a regional level. This means that assets in different grids don’t have a reliable way to share power, which results in inefficiencies. Having one overall grid operator would make this process far more efficient. At the moment, this approach hasn’t been implemented.

The construction of coal-fired power plants also points to an increase in coal use. This sentiment is shared by players in the industry, who also expect coal use to increase in China. For instance, Guangdong Energy Group head of coal management Wu Wenbin stated during the summit that he expected consumption of coal in China to rise by 4% this year alone

The data coming out of China shows that it is likely that other countries around the world may also increase their coal use before tapering off the fraction of the energy mix that this fossil fuel contributes. Coal producers such as Arch Resources Inc. (NYSE: ARCH) may consequently take time before seeing their earnings dropping to a level where the income stream is no longer viable.

Arch Resources Inc. (ARCH), closed Friday's trading session at $161, off by 0.635685%, on 5,449,841 volume. The average volume for the last 3 months is 5.705M and the stock's 52-week low/high is $102.42/$187.60.

Salesforce Inc. (CRM)

The Street, InvestorPlace, Kiplinger Today, Schaeffer's, MarketClub Analysis, Investopedia, MarketBeat, All about trends, StreetInsider, Zacks, StocksEarning, The Online Investor, Trades Of The Day, StreetAuthority Daily, Barchart, Daily Trade Alert, Market Intelligence Center Alert, Money Morning, Early Bird, FreeRealTime, Cabot Wealth, Market Report,, StockEarnings, Wealth Insider Alert, Money and Markets, TipRanks, Louis Navellier, internetnews, Street Insider, TopStockAnalysts, Daily Wealth, ProfitableTrading, SmarTrend Newsletters, GorillaTrades, InvestmentHouse, PROFIT CONFIDENTIAL, Top Pros' Top Picks, Money Wealth Matters, Stansberry Research, The Motley Fool, AllPennyStocks, Investors Alley, Wyatt Investment Research, TradingMarkets, Super Stock Investor, FeedBlitz, The Wealth Report, Trading Concepts, StrategicTechInvestor, Daily Profit, InvestorGuide, Darwin Investing Network, Investment House, MarketWatch, TheStockAdvisors, Uncommon Wisdom, CNBC Breaking News, Stockhouse, The Trading Report, Insider Wealth Alert, INO Market Report, The Night Owl, Millennium-Traders, Stock Tips Network, YOLOTraderAlerts, InvestorsObserver Team, Investing Daily, Trading Markets, IT News Daily, FNNO Newsletters, Market Intelligence Center, MarketTamer, Greenbackers, internet, Trading Tips, StockTwits, SmallCapVoice, The Stock Enthusiast, Daily Markets, Wall Street Daily, Dynamic Wealth Report, Dividend Opportunities, The Street Report, The Best Newsletters, Investment U, Investing Signal, WStreet Market Commentary, Wealth Daily, Inside Trading, Bellwether Report, TradingAuthority Daily, Jim Cramer, Investor Update, InsiderTrades, Investor Guide, The Wall Street Transcript, SureMoney, The Growth Stock Wire, SmartMoneyTrading, Smart Investing Society, The Stock Dork, Eagle Financial Publications, QualityStocks, Todd Horwitz, equities Canada, The Weekly Options Trader, TheOptionSpecialist, TheStockAdvisor, Options Elite, CustomerService, BUYINS.NET, Buttonwood Research, Hit and Run Candle Sticks, Brainy Brands Company Alerts, Average Joe Options, Inside Investing Daily, Chaikin Analytics, PennyStockScholar, Damn Good Penny Picks,, Traders For Cash Flow, PennyOmega, StockOnion, Stocks That Move, Stocks To Watch, Stocktwiter, StreetAuthority Financial, TheTradingReport, SmallCap Network, Trader Prep, SiliconValley, TradersPro, Trading For Keeps, Trading with Larry Benedict, TradingTips, Vantage Wire, Wall Street Greek, Wallstreetlivechat, Wealthpire Inc., Trade of the Week, Penny Pick Finders, Investiv, InvestorsUnderground, iStockAnalyst, Jon Markman's Pivotal Point, Leeb's Market Forecast, Market Authority, Market FN, StockMarketWatch, OTCtipReporter, Investing Futures, Penny Stock Buzz, 24/7 Trader, PennyStockProphet, PennyToBuck, Profitable Trader Authority and Profits Run reported earlier on Salesforce Inc. (CRM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last week, Salesforce Inc. (NYSE: CRM) announced new AI solutions that could reduce workloads for healthcare workers. Salesforce is a cloud-based software company headquartered in San Francisco. The company offers customer relationship management software and applications focused on customer service, sales, analytics, marketing automation and e-commerce.

The first solution, called Einstein Copilot: Health Actions, has been designed to allow physicians to send referrals, book appointments and summarize patient info, including details such as patients’ prescriptions, diagnoses, clinical service requests and tests. By generating a summary using AI, clinicians would save time when looking for this data.

The other solution, Assessment Generation, will permit organizations to digitize health evaluations. This eliminates the need to manually type them.

Both solutions were built on the company’s Einstein 1 Platform, which health organizations use to collate medical data from different sources, including e-health records and insurance claim systems, into a single place. The platform also empowers admins, developers and IT with an artificial-intelligence platform that facilitates the development of automation and generative applications.

Administrative tasks that require a significant labor, such as paperwork, are one of the biggest drivers of burnout among doctors. It doesn’t help that the healthcare system is also short staffed. According to a recently conducted survey, more than 90% of physicians felt burned out regularly, with 64% of them noting that they were overwhelmed by administrative tasks.

To keep up with the ever-piling workloads, surveyed physicians revealed that they spent about 15 hours a week working on these administrative tasks, in addition to their usual work hours. This workload often grows heavier with each passing day, as healthcare data is stored in different formats and databases, which makes it time consuming for physicians to track down required information.

The survey also found that more than 80% of doctors believed AI could help streamline administrative tasks as well as identify anomalies and patterns in patient data, among other tasks. This and the need to consolidate data across the healthcare system has created a significant opportunity for technology companies such as Amazon Web Services, Google and Salesforce, which provide cloud-based customer relationship management tools.

During its announcement, Salesforce asserted that its Einstein Copilot solution would be available for use by the year’s end while its Assessment Generation solution would be available this summer. It is expected that all Einstein Copilot functionalities and features will comply with the Health Insurance Portability and Accountability Act. Regulations under this act protect sensitive patient health information from being disclosed without the patient’s knowledge or consent.

Salesforce Inc. (CRM), closed Friday's trading session at $294.33, off by 2.9639%, on 11,885,105 volume. The average volume for the last 3 months is 90.071M and the stock's 52-week low/high is $178.21/$318.715.

Marathon Digital Holdings Inc. (MARA)

MarketClub Analysis, Schaeffer's, InvestorPlace, QualityStocks, INO Market Report, StockMarketWatch, MarketBeat, StocksEarning, StockEarnings, TradersPro, BUYINS.NET, The Online Investor, Zacks,, InvestorsUnderground, Early Bird, Trades Of The Day, Daily Trade Alert,, TraderPower, The Street, 360 Wall Street, Wall Street Mover, TopPennyStockMovers, PoliticsAndMyPortfolio, BillionDollarClub, FeedBlitz, StreetAuthority Daily, CryptoCurrencyWire, FreeRealTime, Kiplinger Today, Investment House, Wealth Insider Alert, The Wealth Report, Eagle Financial Publications, DreamTeamNetwork, Barchart, AllPennyStocks, Inside Trading, Investment News Daily, Lance Ippolito, ProsperityPub, RedChip, Rick Saddler, Stock Analyzer, Stock Beast, StockOodles, Street Insider, StreetInsider, TradingPub, Wealth Daily and Promotion Stock Secrets reported earlier on Marathon Digital Holdings Inc. (MARA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin surged again, hitting another all-time high. According to Coin Metrics, the leading cryptocurrency’s price soared 3% to $72,022.16, reaching a peak of $72,750.16. The digital currency experienced a volatile surge, marking new records for the first time since November 2021, followed by relatively calmer trading during the weekend.

The influx of investments into U.S. Bitcoin spot ETFs continues to be a significant driving force behind the crypto’s price momentum. CoinShares reported a record-breaking $2.7 billion inflow into digital assets last week, bringing the total investment to $10.3 billion, approaching the 2021 record of $10.6 billion.

However, increased leverage within the crypto market has led to substantial price fluctuations, reminiscent of levels not seen in almost a year. Funding rates have peaked since 2021, coinciding with Bitcoin’s open interest record high. Ether, Bitcoin’s counterpart, surged past $4,000 for the first time since 2021, buoyed partly by Bitcoin’s performance, with a 3% increase to $4,034.00.

Investors are eagerly anticipating the Ethereum network’s upcoming major technical upgrade, nicknamed “Dencun,” expected this week. Historically, the cryptocurrency has rallied leading up to such upgrades, followed by a sell-off by traders during the event.

Alex Saunders, an analyst from Citi, highlighted the potential divergence in price action during the Dencun upgrade due to the prevailing strength of other significant crypto catalysts, including Bitcoin ETFs’ inflow, the looming Bitcoin halving and the possibility of the U.S. Securities and Exchange Commission approving Ether spot ETF trading by May.

Stocks associated with Bitcoin’s performance showed mixed results on Monday. While Coinbase experienced some gains before settling close to flat, Microstrategy saw a 4% increase following its acquisition of roughly 12,000 Bitcoins for more than $821 million.

However, mining companies faced losses, with Marathon Digital Holdings Inc. (NASDAQ: MARA) dropping 12%, CleanSpark falling 16%, Iris Energy declining by 5% and Riot Platforms slipping by 4%. Despite being top gainers in February, these companies have seen a downturn in March as investors anticipate the upcoming halving event.

Meanwhile, U.K. regulators announced approval for exchanges to list the first crypto-linked ETPs, following the approval of Bitcoin spot ETFs in the U.S. two months ago. The regulator’s decision allows recognized exchanges to establish a U.K.-listed market section for crypto-backed ETNs. The London Stock Exchange will start accepting applications for the admission of Ether and Bitcoin ETNs from April this year.

Unlike ETFs, which are asset-holding funds, ETNs are unsecured debt securities issued by banks, typically linked to market indices or benchmarks. They promise to pay out the full index value at maturity and charge lower management fees. Bitcoin proponents believe this move will drive greater institutional investment into cryptocurrencies, positively impacting prices as more substantial investments flow into the market.

Marathon Digital Holdings Inc. (MARA), closed Friday's trading session at $19.32, up 5.9792%, on 58,173,454 volume. The average volume for the last 3 months is 15.492M and the stock's 52-week low/high is $6.61/$34.09.

Coinbase Global Inc. (COIN)

Schaeffer's, InvestorPlace, The Street, MarketClub Analysis, Prfmonline, QualityStocks, Greenbackers, MarketBeat, Zacks, Early Bird, INO Market Report, Kiplinger Today, Investopedia, OTCPicks, SmallCapVoice, Ceocast News, The Online Investor, StockEarnings, The Wealth Report, HotOTC, InsiderTrades, CoolPennyStocks, Daily Trade Alert, StockEgg, Trades Of The Day, StocksEarning, Penny Invest, Stock Stars, Stock Rich, Top Pros' Top Picks, FreeRealTime, BestOtc, Top Gun, CryptoCurrencyWire, CNBC Breaking News, The Stock Psycho, Wealth Daily, StockHotTips, BullRally, HotShotStocks, Energy and Capital, MadPennyStocks, Cabot Wealth, TradersPro, Today's Financial News, bullseyeoptiontrading, Summa Money, StockRich, Stockpalooza, PennyInvest, Smartmoneytrading, FeedBlitz, Profit Confidential, PennyTrader Publisher, PennyStockVille, Pennybuster, Eagle Financial Publications, CRWEWallStreet, Dynamic Wealth Report, Dawn Report, BloomMoney, Blaque Capital Stocks, Atomic Trades, AlphaShark Trading, Early Investing, Stock Analyzer, wyatt research newsletter, WiseAlerts, wealthmintrplus, Wealth Whisperer, TradingPub, Trading with Larry Benedict, TipRanks, StockMister, Penny Stock Finder, Stock Fortune Teller, Green Chip Stocks, Standout Stocks, Round Up the Bulls, Penny Stock Rumble, AllPennyStocks, Momentum Traders, MicrocapVoice, Louis Navellier, Jeff Bishop and Stock Traders Chat reported earlier on Coinbase Global Inc. (COIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Coinbase Global Inc. (NASDAQ: COIN)’s stock prices have gone up significantly amid a surge in Bitcoin prices and even surpassed the listing price set during Coinbase’s direct public offering in 2021. The rise in share prices represents a major turn for the better for a crypto exchange that has dealt with significant challenges since it joined the stock market.

Coinbase share prices have surged by a whopping 60% since the beginning of the year and passed $252 per share this month, Coingape reports. This is the first time in several years that Coinbase shares have cleared the $250 mark and is part of a trend that has seen the company’s shares rise steadily in recent months.

Coinbase’s stock has appreciated by more than 300% during the past 12 months alone, compared to the lows of up to $33 seen during the cryptocurrency winter in 2023. The 2023 crypto winter saw cryptocurrency prices trend lower and lower through the year amid a sharp reduction in trading volume.

However, the crypto market has been in recovery mode since and even managed to regain some of its former glory when Bitcoin prices reached an all-time high of $70,000 as of March 8. Bitcoin’s performance was mostly due to a confluence of factors, such as speculation about the impending Bitcoin halving as well as a surge in investing flow into Bitcoin ETFs (exchange-traded funds), which had a positive effect on the overall cryptocurrency market.

On the other hand, Coinbase’s success was attributed to the crypto exchanges’ strategic partnerships coupled with a heavy presence in the young but swiftly growing Bitcoin ETF space. Coinbase’s exchange division, Coinbase Custody, has also partnered with several asset managers that launched Bitcoin-related Exchange Traded funds in early 2024. These partnerships are predicted to provide Coinbase with an estimated $25to $30 million in revenue from different fees.

Additionally, the crypto exchange’s operational performance is growth oriented and resilient, allowing it to generate $995 million in net revenue in the last quarter of 2023. This represented a 45.2% increase in net income from Q3 2023 ($825 million) and is an indication of the exchange’s improving performance.

An increasing number of market analysts have taken notice of Coinbase’s improving performance in their analysis of the crypto market. JPMorgan analyst Ken Worthington has changed Coinbase’s stock rating from underweight to neutral at $80, partly due to the influence of Bitcoin ETFs on the cryptocurrency system.

Coinbase Global Inc. (COIN), closed Friday's trading session at $242.36, up 3.7189%, on 17,256,270 volume. The average volume for the last 3 months is 3,691 and the stock's 52-week low/high is $46.43/$271.65.

The QualityStocks Company Corner

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

New research has facilitated the development of an artificial intelligence model that can detect illnesses by examining medical images. This model can accurately pick out tumors and provide reasons for every diagnosis given via visual maps. This tool's development marks an important advancement in the healthcare technology field, because it will simplify the process of detecting illnesses as well as the diagnosis process. The study was led by Beckman Institute graduate research assistant Sourya Sengupta, who highlighted that the study's focus was on detecting cancer in its early stages. With other companies such as Astrotech Corp. (NASDAQ: ASTC) working to bring to market more next-gen medical diagnostic tools, it is likely to get a lot easier to diagnose a wide variety of diseases with increased accuracy.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.


Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Friday's trading session at $8.88, up 7.3203%, on 9,167 volume. The average volume for the last 3 months is 179 and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

Diamond Lake Minerals (OTC: DLMI), a leading multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered security tokens, was featured in a recent Benzinga article. The piece discussed the tokenization of real estate assets and DLMI's role as one of the companies leading this quiet revolution. According to the article, tokenization, which refers to the process of converting physical assets like real estate or precious metals into digital tokens that can be traded on a blockchain network, allows for easier and more efficient transfer of ownership and increased liquidity. The article stated, "DLMI has spent a substantial amount of time and resources under the leadership of its CEO Brian J. Esposito working on the program of converting real estate assets into blockchain-based digital tokens in its ecosystem."

To view the full article, visit

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Friday's trading session at $4.55, up 21.3333%, on 400 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $15.11/$.

Recent News

Turbo Energy S.A. (NASDAQ: TURB)

The QualityStocks Daily Newsletter would like to spotlight Turbo Energy S.A. (NASDAQ: TURB).

EU raised 2030 binding renewable energy target to a minimum of 42.5%, aims to become climate-neutral by 2050

U.S. set goal of 100% clean energy by 2035

TURB aligned with renewable energy shift with Sunbox Home and Sunbox Industry

TURB's all-in-one systems leverage AI to improve efficiency, prevent price shocks, and maximize cost savings

Turbo Community allows members with large PV installations to gain ownership of production, store extra power, and sell energy to market

Turbo Energy (NASDAQ: TURB) is a designer, developer and manufacturer of photovoltaic energy generation, management and storage equipment. The company is seeking to harness artificial intelligence ("AI") in the manufacture and development of its residential solutions, which allow households to capture and store solar energy. "The company's ‘Sunbox Home' system encompasses an all-in-one AI-powered energy storage solution, designed to assist households in managing their power consumption. Directly linked to a household's solar panel generation unit, the Sunbox system allows users to choose between settings including ‘maximum consumption' or ‘maximum savings,' to conserve a portion of its energy reserves in the event of unexpected electricity blackouts or rather, sell excess power back onto the grid. The groundbreaking energy storage system additionally boasts the capacity to track weather forecasts, thus ensuring its batteries are fully charged in the event of a storm," explains a recent article. "Turbo Energy's artificial intelligence and optimization system is the best on the market," said Turbo Energy CEO Mariano Soria. "[In addition to having] the capacity to offer the end consumer the best solution in economic savings, [our] software is the basis for the continued development of the company [as well as giving us] the ability to incorporate other elements in the future. We envision the ability to make use of it, not only for individuals but for groups such as energy communities or virtual power plants."

To view the full article, visit

Turbo Energy S.A. (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally.

Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship product, the Sunbox, an all-in-one device that integrates most of the equipment required for a residential photovoltaic installation. The Sunbox is powered by AI and features a software system that monitors the generation, use and management of photovoltaic energy by analyzing large amounts of data related to energy generation, consumption, market prices and weather forecasts. This AI system optimizes battery usage, reducing electricity bills and providing peak-use reduction and uninterruptible power supply functions.

Turbo Energy currently sells its photovoltaic energy equipment primarily through distributors for residential consumers in Spain, but it possesses the expertise and international perspective to expand its product portfolio into industrial and commercial scale and markets, as well as advancing the internationalization process it has already started. The company plans to expand into the industrial photovoltaic sector with its new Sunbox, launched in 2023, in higher power and capacity variants. Its goal is to become a significant player in this sector and contribute to the growth of renewable energy solutions.

The company was incorporated in 2013 and is based in Valencia, Spain. It operates as a subsidiary of Umbrella Solar Investment S.A.


Lithium-Ion Batteries

Turbo Energy is one of the leading companies that introduced lithium-ion batteries for photovoltaic energy storage in Spain. Primarily for the home energy storage market, the company’s batteries have capacities from 2.24 kWh to 5.1 kWh in 24 and 48 volts. In addition, its 48V / 5.1 kWh units are available in a dual battery system.


The inverter converts the direct current produced by the photovoltaic panels into alternating current that can be used by household appliances. It also regulates battery charging and discharging based on energy needs and optimizes utilization of generated renewable energy. Turbo Energy currently offers multiple models that cover most household installations.

All-in-One Sunbox

This product incorporates inverters, batteries and the rest of the components necessary to operate and protect the photovoltaic installation. This saves installation cost and assembly and configuration time while preventing errors. Notably, the latest Sunbox models also offer an EV charging option.

Software System

In communication with the inverter, the company’s software monitors energy flows between the photovoltaic panels, household consumption, storage and an optional electric vehicle charging station. The software allows users to customize an automatic backup mode based on weather forecasts, or manually select which part of the battery will be reserved for possible power outages. It also allows the battery to be used in a peak shaving mode, which leverages AI to trigger battery power when grid energy is most expensive, effectively reducing the amount of high-cost power drawn from the grid.

Market Opportunity

According to a report by Fortune Business Insights, a global research and reporting firm, the solar energy storage battery market was estimated to be worth $3.33 billion in 2022 and is projected to reach a value of more than $20 billion by 2030, marking a CAGR of 24.2% over the forecast period.

These batteries are crucial components of renewable energy systems, allowing for the storage of excess electricity generated by solar panels, so it can be used during times of no or low sunlight. By storing energy and supplying it when needed, these batteries reduce reliance on the power grid and maximize self-consumption while helping users avoid peak electricity rates. They also contribute to the transition toward a cleaner and more sustainable energy future by enabling residential consumers and businesses to use solar power even when the sun is not shining.

Management Team

Enrique Selva Bellvís is the CEO and founder of the Umbrella Group. In addition, he serves as vice-president of the Valencian Association of Energy Sector Companies industry group. Before his career in the solar energy sector, he was the founder and CEO of Innova Ingenieros Consultores. He holds a degree in industrial engineering with a specialization in energy from the Polytechnic University of Valencia and completed the Management Development Programme at the IESE Business School.

Mariano Soria is the Chief Innovation Officer for the Umbrella Group and serves as General Manager of Turbo Energy. He was CEO of Punt Moble XXI S.L. and continues to serve on that company’s board. Before that, he was the General Manager of REJMAR S.A., a land development company. He received his degree in industrial engineering and industrial organization from the Polytechnic University of Valencia, and his MBA from the European University of Madrid.

Alejandro Moragues is CFO of Turbo Energy. Previously, he held the position of Senior Corporate Auditor for U.S. company Euronet Worldwide Inc. and was an external auditor for PricewaterhouseCoopers. He holds a bachelor’s degree in business administration and management from the Polytechnic University of Valencia.

Manuel Cercos is Chief Commercial Officer at Turbo Energy. Previously, he held positions at Técnicas Aplicadas en Baterías S.L., where he served as Sales Director and Sales Manager. Before that, he worked as a Sales Technician at DAISA.

Turbo Energy S.A. (NASDAQ: TURB), closed Friday's trading session at $1.245, up 5.5085%, on 8,764 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.855/$7.90.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

Experts say Shanghai's latest plan to improve Environmental, Social and Governance ("ESG") standards is compatible with the country's developmental concept of "innovation, coordination, green, openness and sharing." With ESG becoming an increasingly integral cog in the corporate world, Shanghai officials recently published a three-year plan designed to boost the city's ESG capabilities. The Action Plan for Accelerating the Improvement of Environmental, Social & Governance ("ESG") Capabilities of Foreign-related Enterprises in Shanghai (2024-2026) was released by the Shanghai Commission of Commerce to improve ESG principles among corporations operating in the city. It outlines 12 key measures across three major actions: improving ESG market efficiency, enhancing ESG enterprises and optimizing the ESG service system. Sustainability data disclosure may currently be challenging to standardize, but that isn't stopping companies such as First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) from implementing these principles in their operations in order to reap the benefits that come with putting ESG at the core of everything a company does.

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.



Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Friday's trading session at $0.0632, up 5.3333%, on 38,001 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.047785/$0.154.

Recent News


The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

GEMXX (OTC: GEMZ), a leading mine-to-market company focused on mining and producing jewelry out of gold and ammolite, recently provided a positive outlook covering India's burgeoning markets for colored gemstones and jewelry. "In the press release, GEMXX highlighted recent industry forecasts, which anticipate that the jewelry market in India will surge by US$21.54 billion between 2023 and 2027, representing an impressive CAGR of 5.54%. This growth, GEMXX holds, is positioning India as a key player in the global jewelry arena. The company also singled out the colored gemstones market in India, which analysts expect to reach US$707.8 million in 2024 and US$1.9 billion by 2033, marking a robust 10.5% CAGR between 2023 and 2033," a recent article reads. "According to Jay Maull, CEO of GEMXX Corp., ammolite, a relatively recent addition to the Indian colored gemstone market, has the potential to attract a significant portion of buyers seeking something innovative or distinct from conventional colored gemstones. Against this backdrop, GEMXX is positioned to take advantage of this growing trend by offering a wide array of ammolite products to cater to the evolving preferences of the Indian market."

To view the full article, visit

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.


GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Friday's trading session at $0.037, up 32.1429%, on 41,362 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0172/$0.75.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Upstream, a MERJ Exchange market and trading app, has published a blog discussing how it empowers companies to engage with their shareholders and enhance investor relations ("IR") through dual listing. The blog, by Anastasia Samaras, notes that Upstream puts marketing at the forefront of dual listings, offering issuers a media package with ~$100k of IR value, featuring interviews, PRs, videos, and other collateral to amplify visibility and introduce companies to a global investor base who can access their shares on Upstream.

"Upstream goes beyond traditional IR by providing smart-contract-powered shareholder engagement tools. Issuers are taking advantage of Upstream's web3 technology with digital coupon campaigns to engage with shareholders and drive awareness or sales," writes Samaras. "By joining Upstream, you gain access to a global community and a suite of innovative tools to build deeper connections, drive revenue and achieve long-term success."

To view the full blog, visit

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.


Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (, an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News


Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

Astiva Health is a leading healthcare provider that specializes in delivering personalized and comprehensive solutions to diverse communities. The company is leading the charge in creating essential healthcare solutions tailored for the expanding aging Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the population requiring more support. "The company is proactively meeting the unique needs of this group by providing healthcare services that are culturally sensitive and honor the diverse traditions and values across Asian cultures… Astiva Health's commitment to culturally sensitive care acknowledges the importance of traditional values such as filial piety and communal living, which are prevalent across various Asian cultures. By offering comprehensive health plans that promote independence while respecting cultural practices, Astiva addresses the challenges of traditional caregiving structures," a recent article reads. "Aware of the barriers faced by Asian American seniors, including language difficulties and economic disparities, Astiva Health is dedicated to providing affordable healthcare solutions."

To view the full article, visit

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News


Sigyn Therapeutics Inc. (OTCQB: SIGY)

The QualityStocks Daily Newsletter would like to spotlightFathom Sigyn Therapeutics Inc. (OTCQB: SIGY).

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, is currently focused on the development of four therapeutic candidates to address clearly defined limitations in global health. These include the ImmunePrep(TM) platform to enhance the performance of immunotherapeutic antibodies to treat cancer, ChemoPrep(TM) to enhance the targeted delivery of chemotherapy, ChemoPure(TM) to reduce the toxicity of chemotherapy, and Sigyn Therapy(TM) to address pathogen-associated conditions that are beyond the reach of drugs. "Though highly valued, [immunotherapeutic antibodies to treat cancer] are limited by poor delivery to cancer cell targets and as a result, most patients do not respond to therapy. Inhibiting the delivery of therapeutic antibodies are circulating decoys that display the binding site target of the antibody and can be highly prevalent in the bloodstream. As a result, a significant portion of an antibody dose can bind to circulating decoys instead of cancer cell targets. ‘Amazingly, with more than 1,000 therapeutic antibodies being evaluated by human studies, there was no strategy to reduce the circulating presence of decoys that block the delivery of these drugs,'" reads a recent article that contains excerpts from Sigyn Therapeutics chairman and CEO James A. Joyce's letter to shareholders.

"To fill this gap, Sigyn Therapy designed the ImmunePrep platform, whose implementation is based on a reverse decoy mechanism. This mechanism will leverage the use of therapeutic antibodies to create extracorporeal blood purification devices that extract antibody decoys from the bloodstream before the normal delivery of the same therapeutic antibodies."

To view the full article, visit

Sigyn Therapeutics Inc. (OTCQB: SIGY) is a development-stage medical technology company headquartered in San Diego, California. The company’s therapeutic candidates include Sigyn Therapy™ to address pathogen-associated inflammatory disorders, the ImmunePrep™ platform to enhance the performance of immunotherapeutic antibodies, ChemoPrep™ to improve the delivery of cancer chemotherapy and ChemoPure™ to reduce the toxicity of chemotherapy.

Sigyn created each of these technologies with two prerequisites in mind: 1) they must offer to overcome a clearly defined limitation in healthcare, and 2) their successful clinical advancement would offer a potential competitive advantage to established therapeutic organizations.

Sigyn Therapy™

The company is advancing Sigyn Therapy™ to treat pathogen-associated inflammatory disorders that are not addressed with FDA approved drugs. Candidate treatment indications include community-acquired pneumonia, drug-resistant virus and bacterial infections, endotoxemia and sepsis, which is the leading cause of hospital deaths in the United States.

The technology has the following attributes and capabilities.

  • Sigyn Therapy™ incorporates a formulation of adsorbent components that have more than 200,000 square meters (~50 acres) of surface area on which to adsorb and remove therapeutic targets from the bloodstream.
  • In vitro studies have demonstrated the ability of Sigyn Therapy™ to eliminate life-threatening pathogen and inflammatory disease targets from human blood plasma. In these studies, 12 relevant targets, including viral pathogens, bacterial toxins and inflammatory cytokines, were validated. Subsequent animal studies were completed at the University of Michigan.
  • Sigyn Therapy™ is highly efficient, as the entire circulatory system of a patient can pass through the device ~15-times during a four-hour treatment.
  • To allow for broad deployment, Sigyn Therapy™ is designed for use on the established infrastructure of dialysis and continuous renal replacement machines already located in hospitals and clinics around the world.

First-in-human studies of Sigyn Therapy™ plan to enroll dialysis dependent end-stage renal disease (ESRD) patients with endotoxemia and concurrent inflammation, which are highly prevalent and associated with increased mortality in the ESRD population. There are more than 550,000 individuals with ESRD in the United States, which result in approximately 85 million dialysis treatments being administered each year.

The ImmunePrep™ Platform

Immunotherapeutic antibodies to treat cancer are among the most valued assets in global medicine. However, these drugs suffer from a severe limitation: they are poorly delivered to cancer cell targets, and, as a result, a majority of patients do not respond to therapy.

The Sigyn team recognized that just a small fraction of an antibody dose reaches its cancer cell target, yet a significant portion of the same dose can be sequestered by circulating decoys that display the target (antigen) binding site of the antibody. In response, Sigyn designed the ImmunePrep™ platform to leverage the use of therapeutic antibodies to create extracorporeal blood purification devices that sweep antibody decoys from the bloodstream prior to the subsequent infusion (normal delivery) of the same therapeutic antibody.

The company believes its reverse decoy mechanism will increase the availability of antibodies to interact with their intended disease targets, and, simultaneously, the devices will also extract disease targets from the bloodstream to further improve patient benefit.

The opportunity to enhance the performance of therapeutic antibodies is significant. Consider that Pfizer’s $43 billion acquisition of Seagen Inc. and Amgen’s $27.8 billion acquisition of Horizon Therapeutics were the highest valued M&A deals of 2023. In both cases, transaction values were driven by market-cleared antibody assets.

Perhaps more revealing were the values placed on clinical-stage (pre-revenue) therapeutic antibody candidates. In this regard, consider Merck’s $10.8 billion acquisition of Prometheus Biosciences and Roche’s $7 billion acquisition of a clinical-stage antibody from Roivant Sciences.

In the backdrop of these M&A transactions, the immune checkpoint antibody Keytruda (Merck) became the world’s best-selling (non-vaccine) drug in 2023, with anticipated revenues of ~$24 billion.

ChemoPrep™ and ChemoPure™

Recent scientific publications have reported that only 1% of chemotherapy is delivered to the tumor cell targets of cancer patients. In response, the Sigyn team designed ChemoPrep™ to overcome a delivery limitation of the most commonly administered drug to treat cancer.

The company is developing ChemoPrep™ to reduce the circulating presence of tumor-derived exosomes (tumor exosomes), which interfere with chemotherapy delivery. High concentrations of tumor exosomes in the bloodstream correspond with poor treatment outcomes, whereas low concentrations of tumor exosomes correspond with more favorable outcomes. As compared to non-cancer subjects, exosome populations are reported to be 10x to 500x higher in the bloodstream of cancer patients. Based on these factors, the company believes there is a compelling scientific rationale to reduce the circulating presence of tumor exosomes prior to chemotherapy administration.

Inversely, the Sigyn team recognized that if 99% of chemotherapy was missing its target, then there was a need to eliminate off-target chemotherapy from the bloodstream to reduce toxicity and limit organ damage. This factor led to the design of ChemoPure™ to reduce treatment toxicity by reducing the presence of off-target chemotherapy from the bloodstream. The company believes that a reduction in chemotoxicity may also alleviate treatment-related fatigue and potentially temper the long-term health consequences associated with chemotherapy administration.

Management Team

James A. Joyce is Co-Founder, Chairman and CEO of Sigyn Therapeutics. He has more than two decades of public company CEO and corporate board leadership experience and is an inventor or co-inventor of 20 pending or issued patents, including those underlying ImmunePrep, ChemoPrep, ChemoPure and Sigyn Therapy. Previously, he was founder and CEO of Aethlon Medical, a therapeutic technology company that he built from a start-up to a Nasdaq-traded company. Under his leadership, Aethlon developed the first medical device to receive two breakthrough device designations from the FDA. Mr. Joyce graduated from the University of Maryland.

Annette Marleau, Ph.D., is Chief Scientific Officer at Sigyn Therapeutics. Prior to joining the company, she was Chief Technology Officer at Immunicom Inc. and Director of Research at Aethlon Medical Inc. Additionally, she is an inventor on pending and issued patents underlying blood purification therapies targeting cancer, inflammatory disorders and life-threatening infectious diseases. She holds a Ph.D. from Western University, an M.S. from the University of Guelph and a B.S. from the University of Waterloo in Canada.

Jerry DeCiccio, CPA, is CFO at Sigyn Therapeutics. He has more than 40 years of financial industry experience. Previously, he was CFO/COO at Intech Electromechanical, CFO/COO at GTC Telecom, CFO at Incomnet Communications and President at Cerebain Biotech Corp. He also served in senior financial roles at Parker Hannifin Corp., Waste Management Inc. and Newport Corp. He earned a bachelor’s degree in accounting and business administration from Loma Linda University and an MBA in finance and systems technology from the University of Southern California.

Sigyn Therapeutics Inc. (OTCQB: SIGY), closed Friday's trading session at $5, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $2.08/$12.80.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

According to a recently published article, some Drug Enforcement Administration officials may be resisting calls to move cannabis to a lower schedule. This has created tension with the White House, especially as the president continues to laud his role in spearheading the marijuana review. Certain officials appear to be contesting scientific findings from the U.S. Health and Human Services, which were the basis of the department's recommendation that cannabis be resclassified under the Controlled Substances Act. The article highlights that the officials are concerned about issues linked to THC potency and are still not convinced by the conclusion made by the health department on marijuana having medical value. It is important to note that the rescheduling of cannabis would not legalize the drug at the federal level. It would, however, allow marijuana businesses in legal states to claim federal tax deductions. Currently, state-legal businesses are barred from doing so under Section 280E of the IRS. This regulation bars businesses from deducting business expenses from income linked to the trafficking of substances under the first two schedules of the Controlled Substances Act. Additionally, rescheduling would eliminate certain barriers that prevent research on marijuana from advancing. Industry players such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) will be waiting to hear the final scheduling decision that the DEA makes at the end of its review process.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.


MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Friday's trading session at $0.034, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Despite significant government and corporate efforts to push electric vehicle adoption, many Americans are disinterested in purchasing battery electric vehicles (BEVs). That said, battery electric vehicle (BEV) sales in the country are on the rise, and BEVs currently account for nearly 10% of all new vehicle registrations. Hybrid electric cars are more popular among consumers and have higher adoption rates because they allow drivers to reduce their emissions without ditching internal combustion engine cars completely. High electric vehicle prices are also hindering public interest in electric vehicles.  Even though EV prices have fallen slightly in recent months, thanks to a price discount war between Tesla and Chinese EV makers, prices are still higher than traditional internal combustion engine cars. Coupled with high-interest rates and a soaring cost of living, high prices are contributing to the rising disinterest in electric cars among American drivers. Electric vehicle makers such as Mullen Automotive Inc. (NASDAQ: MULN) now have the task of wooing these disinterested members of the public so that the uptake of EVs can accelerate.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Friday's trading session at $5.5, off by 3.8462%, on 631,840 volume. The average volume for the last 3 months is 1.51M and the stock's 52-week low/high is $5.48/$3584.25.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech (NASDAQ: SNES) is dramatically improving pest management technicians' toolboxes with its patent-pending Evolve(R) soft bait birth control product for rodents, which joins the liquid ContraPest(TM) product in providing non-lethal solutions to reducing rodent populations. "The patent-pending Evolve(TM) soft bait has a sausage-like appearance and poses little or no risk to human health or the environment – a significant advantage over poisons used to kill rats. SenesTech's products are the first, and still the only, such rat contraceptives registered with the U.S. Environmental Protection Agency (‘EPA') that target both male and female rats… The company recommends using its Birth Control for Rats(TM) products in tandem with other rodent control products, since rats that consume Evolve(TM) or ContraPest(R) will continue to live out their life cycles for months, just without adding new generations of pups. But SenesTech's products can be used on their own if preferred," a recent article reads. "The company's reach is expanding globally – in addition to outlets across the United States, government entities in South Africa, the Maldives and, last month, the United Arab Emirates (‘UAE') market have entered agreements with the company."

To view the full article, visit

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.


SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Friday's trading session at $0.7305, off by 3.8816%, on 100,230 volume. The average volume for the last 3 months is 2.147M and the stock's 52-week low/high is $0.52/$29.04.

Recent News

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

The Canadian Shield hosts numerous nickel, copper, gold, and platinum group metals

Fathom targets high-grade nickel sulfide discoveries for use in EV and green energy markets

Fathom operates the Albert Lake Project and the Gochager Lake Project, both located in Saskatchewan's Trans Hudson Corridor

Favorable results revealed from recent drilling at the Albert Lake Project

Company recently closed the second and final tranche of its non-brokered offering, total gross proceeds totaled $4,571,063 when combined with the first tranche

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a Canadian natural resource exploration and development company, is keen on targeting high-grade nickel sulfide developments for use in the rapidly growing electric vehicle market. "Led by a management team boasting over 100 years of combined mining and exploration experience and having raised gross proceeds of approximately C$7.5 million over the past six months to fund its incremental exploration work, Fathom Nickel has set its sights on developing two key nickel projects – the Albert Lake and Gochager Lake projects," a recent article reads. "With total EV sales anticipated to swell from 2.5 million vehicles in 2020 to a massive 31.1 million electric automobiles in 2030, EVs are expected to comprise as much as 32% of total new vehicle sales within the next six years. Moreover, and with nickel-based technologies expected to comprise an ever-greater proportion of EV batteries going forward, Fathom Nickel is well situated to capitalize on the world's ongoing energy transition and provide clean, green Canadian nickel." To view the full article, visit

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.


The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Friday's trading session at $0.068, off by 5.8172%, on 103,140 volume. The average volume for the last 3 months is 114,018 and the stock's 52-week low/high is $0.055/$0.2634.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.